Searching for a safeguard
Penn State researchers are applying decades of expertise toward the development of complementary COVID-19 vaccine candidates.
Staying home, having access to primary care, and limiting contagion hubs may curb COVID-19 deaths
New study uses novel statistics to understand why some regions in Italy were hit harder than others during the first wave of the pandemic.
Origins of an outbreak
Penn State biologist Maciej Boni tracks the SARS-COV-2 virus to its source.
Will COVID-19 become a mostly childhood disease?
COVID-19 risks may shift from older adults to younger children as the SARS-CoV-2 virus becomes endemic, according to new modeling results.
Researchers discover potential therapeutic targets on SARS-CoV-2 Spike protein
A team of scientists has discovered additional locations on the Spike protein that may not only help to explain how certain mutations make emerging variants more infectious but also could be used as additional targets for therapeutic intervention.
Fighting Covid with Covid
Researchers design new COVID-19 therapy that uses the COVID-19 virus against itself.
Behavior limits COVID-19 spread between University and community
The Penn State-led Centre County COVID-19 Data 4 Action Project reveals new insights about behavior and infection rates in Centre County during the pandemic.
A potential new antiviral drug for COVID-19
An experimental drug may be a promising oral antiviral treatment for COVID-19, according to a new study that includes Penn State scientists.
The evolution of SARS-CoV-2 could undermine the effectiveness of vaccines that are currently under development, according to a new study by Penn State researchers.
An international research team has found that the lineage that gave rise to the SARS-COV-2 virus has been circulating in bats for decades.
Interdisciplinary Response to pandemic
Penn State's Manufacturing and Sterilization for COVID-19 (MASC) Initiative has more than 350 members from across the University.
Penn State's supercomputer takes on COVID-19
Researchers are using Penn State's supercomputer to address COVID-19 and problems created by the pandemic.
Global relationships aid Penn State faculty disease expert on COVID-19
Professor of Biology Matthew Ferrari uses global connections to advise Univeristy on COVID-19 pandemic.
New decontamination protocol permits reuse of N95 respirators
Aerosolized hydrogen peroxide inactivates viruses while maintaining proper mask fit.
Killing coronavirus with UV light
Penn State researchers explore how to kill coronavirus with a handheld ultraviolet light device.
Wastewater sampling may give advanced warning of potential COVID-19 outbreaks
Wastewater sampling for coronavirus could alert University decision makers to a potential outbreak several days before individuals exhibit symptoms of an infection.
Movment affecting transmission
Nita Bharti has been awarded funding to study how people’s movement impacts COVID-19 transmission.
Virus protein takes over
Jean-Paul Armache awarded funding to study how a coronavirus protein takes over human protein-making machinery.
Seeking Antiviral Targets
Joyce Jose has been awarded seed funding to search for antiviral and vaccine targets in SARS-Cov-2.
Vaccines against 10 diseases prevented 37 million deaths in last 20 years
Vaccine programs in low- and middle-income countries have prevented 37 million deaths in the last 20 years – 36 million of which have been in children under age five.
China’s control measures may have prevented 700,000 COVID-19 cases
China’s control measures during the first 50 days of the epidemic may have delayed the spread of the virus to cities by several days.
Another common cold virus?
A new model by researchers at Penn State and Emory predicts SARS-CoV-2 will eventually become endemic and mild, not unlike the common cold.
Mortality rises among public when health workers get sick in an outbreak
When healthcare workers become ill during a disease outbreak, overall case counts and mortality rates may significantly increase, according to a new model created by researchers at Penn State.
Cremer group developing sensors to detect coronavirus in enclosed spaces
“With the advent of the coronavirus pandemic, we quickly turned our attention to building a platform for airborne monitoring of SARS-CoV-2.”
Study finds short window for donating convalescent plasma to COVID-19 patients
The optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy is within 60 days of the onset of symptoms, according to a new Penn State-led study.
Models project COVID-19 cases may spike in May, before sharply declining by July
Frst-ever multi-model effort conducted by Penn State biologists in collaboration with Centers for Disease Control and Prevention.